Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

NCT05480904 · View on ClinicalTrials.gov ↗

Study Summary

The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.

Interventions

  • OTHER Neurocognitive (Thinking) Testing
  • DIAGNOSTIC_TEST CNS Vital Signs (Thinking) Testing
  • OTHER Health Questionnaires, Sleep Surveys & Sleep Diary
  • DIAGNOSTIC_TEST Echocardiography/EKG
  • DIAGNOSTIC_TEST Pulmonary Function

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital — Memphis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-04-17
Est. Completion 2027-01

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05480904

The ClinicalTrials.gov registry entry for NCT05480904 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 441 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Solid Tumor appearing as the primary indexed condition, and to 5 interventions — of which Neurocognitive (Thinking) Testing is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05480904 reports 1 study location spanning 1 distinct geographic area — top geographies include Tennessee. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05480904 about?

NCT05480904 is a clinical study titled "Characterizing Sleep Among Long-term Survivors of Childhood Cancer". The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objec...

What is the current status of trial NCT05480904?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-04-17. Estimated completion is 2027-01.

What conditions does trial NCT05480904 study?

This clinical trial studies the following conditions: Solid Tumor, ALL, Adult, CNS Tumor. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05480904?

The interventions under investigation include: Neurocognitive (Thinking) Testing (OTHER), CNS Vital Signs (Thinking) Testing (DIAGNOSTIC_TEST), Health Questionnaires, Sleep Surveys & Sleep Diary (OTHER), Echocardiography/EKG (DIAGNOSTIC_TEST), Pulmonary Function (DIAGNOSTIC_TEST). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05480904?

This trial is sponsored by St. Jude Children's Research Hospital, which has 441 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05480904 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial